In2c Global Pharma Private Limited
About In2c Global Pharma Private Limited
Data last updated:
In2c Global Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 21 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2013PTC091166. Its GSTIN is 36AADCI5882J2Z4 (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sridevi Rao Cherala and Venkat Narayan Rao Cherala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 83 Whisper Valley Raidurg, Hyderabad, Telangana, India – 500008.
As per the financials filed for FY 2025, the company reported a revenue of ₹52 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹21.07 Lakh (net margin 40.5%) and EBITDA of ₹26.57 Lakh (EBITDA margin 51.1%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 20% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
In2c Global Pharma has one previous CIN (Corporate Identification Number): U24233AP2013PTC091166. The current CIN is U24233TG2013PTC091166, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2013PTC091166 | Current |
| U24233AP2013PTC091166 | Previous |
Contact details
In2c Global Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address# 83 Whisper Valley Raidurg, Hyderabad, Telangana, India – 500008
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of In2c Global Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of In2c Global Pharma is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of In2c Global Pharma Private Limited, buy the company report.
Financials of In2c Global Pharma Private Limited
FY 2025 filings availableIn2c Global Pharma Private Limited reported revenue of ₹52 Lakh (up 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 40% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 20%. EBITDA rose 567% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 51.1% | ||||
| Net Profit Margin | 40.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of In2c Global Pharma Private Limited, buy the company report.
Board of directors of In2c Global Pharma Private Limited
In2c Global Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sridevi Rao Cherala Also directs: Domos Gardening Services Private Limited | Director | 03 Jan 2020 | 6 Years 9 Months | Current |
| Venkat Narayan Rao Cherala Also directs: Domos Gardening Services Private Limited | Director | 21 Nov 2013 | 12 Years 11 Months | Current |
Auditor
In2c Global Pharma Private Limited is audited by RAMU & RAVI for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMU & RAVI | FY 2020 | 006610S |
Shareholding
The shareholding of In2c Global Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of In2c Global Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving In2c Global Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for In2c Global Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
In2c Global Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCI5882J2Z4 | Telangana | Active | 11 Jul 2018 |
To see the full GST registrations and return filing status of In2c Global Pharma Private Limited, buy the company report.
Recent activity
In2c Global Pharma Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Sridevi Rao Cherala ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
In2c Global Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 21 November 2013 (13+ years old) and is registered under CIN U24233TG2013PTC091166.
In2c Global Pharma has 2 current directors:
- Sridevi Rao Cherala - Director
- Venkat Narayan Rao Cherala - Director
The latest financial statements of In2c Global Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of In2c Global Pharma is 36AADCI5882J2Z4, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of In2c Global Pharma is U24233TG2013PTC091166. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
In2c Global Pharma was incorporated on 21 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sridevi Rao Cherala ceased to be Additional Director on 31 Dec 2020. Laxmi Narayan Prasad Mangipudi ceased to be Director on 03 Jan 2020. Sridevi Rao Cherala was appointed as Director on 03 Jan 2020. In2c Global Pharma has 4 board changes on record in total.
The registered office of In2c Global Pharma is at # 83 Whisper Valley Raidurg, Hyderabad, Telangana, India – 500008.
In2c Global Pharma operates in the business outsourcing industry, in the business and IT consulting segment.
The compliance status of In2c Global Pharma is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.